1
MRNA stock price surged 8.84% in the last trading session.
2
Moderna stock price took a reversal from the level of $62.92 after earning reports.
Moderna has become famous for its COVID-19 vaccine, which is the only product it has right now. However, the company has plans to launch more than 15 products in the next five years. These products could change the game for the company, as they could make the annual revenue go up to $30 Billion.
The Moderna stock shot up on the back of Moderna’s Covid-19 vaccine.Moderna is planning to launch 15 new products over the next 5 years, and expects revenue to go up to $30 Billion. The new products will be for diseases, cancer, breathing problems among other ailments.
Moderna Earnings Results
Moderna (NASDAQ: MRNA) reported revenue of $1.83 Billion showcasing a year-over-year decline of 45.6% and EPS of -$1.39 for the span of time compared to $2.53 a year ago.
When the revenue compares to the Zacks Consensus Est
We współpracy z: https://www.thecoinrepublic.com/2023/11/04/moderna-stock-mrna-earnings-exploring-the-future-potential/
